156 related articles for article (PubMed ID: 21870430)
1. Anti-depressant-like activity of a novel serotonin type-3 (5-HT3) receptor antagonist in rodent models of depression.
Gupta D; Devadoss T; Bhatt S; Gautam B; Jindal A; Pandey D; Mahesh R
Indian J Exp Biol; 2011 Aug; 49(8):619-26. PubMed ID: 21870430
[TBL] [Abstract][Full Text] [Related]
2. Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Bhatt S; Mahesh R; Devadoss T; Jindal A
Indian J Exp Biol; 2013 Jun; 51(6):435-43. PubMed ID: 23926691
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
Kumar B; Jindal A; Pandey DK; Bhatt S; Devadoss T; Mahesh R
Indian J Exp Biol; 2012 Sep; 50(9):625-32. PubMed ID: 23140020
[TBL] [Abstract][Full Text] [Related]
7. QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations.
Kurhe Y; Mahesh R; Gupta D; Devadoss T
Eur J Pharmacol; 2014 Oct; 740():611-8. PubMed ID: 24973694
[TBL] [Abstract][Full Text] [Related]
8. Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
Mahesh R; Rajkumar R; Minasri B; Venkatesha Perumal R
Pharmazie; 2007 Dec; 62(12):919-24. PubMed ID: 18214343
[TBL] [Abstract][Full Text] [Related]
9. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.
Pandey DK; Devadoss T; Modak N; Mahesh R
Indian J Med Res; 2016 Oct; 144(4):614-621. PubMed ID: 28256473
[TBL] [Abstract][Full Text] [Related]
11. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
Dhar AK; Mahesh R; Jindal A; Bhatt S
Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
Gay BM; Prigol M; Stein AL; Nogueira CW
Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression.
Devadoss T; Pandey DK; Mahesh R; Yadav SK
Pharmacol Rep; 2010; 62(2):245-57. PubMed ID: 20508279
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
Freitas AE; Budni J; Lobato KR; Binfaré RW; Machado DG; Jacinto J; Veronezi PO; Pizzolatti MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):335-43. PubMed ID: 20026371
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
Bhatt S; Mahesh R; Jindal A; Devadoss T
Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
Gupta D; Radhakrishnan M; Kurhe Y
Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
[TBL] [Abstract][Full Text] [Related]
17. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Yi LT; Xu HL; Feng J; Zhan X; Zhou LP; Cui CC
Physiol Behav; 2011 Jan; 102(1):1-6. PubMed ID: 20951716
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
Bhatt S; Mahesh R; Jindal A; Devadoss T
Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308
[TBL] [Abstract][Full Text] [Related]
19. Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.
Pandey DK; Rajkumar R; Mahesh R; Radha R
J Pharm Pharmacol; 2008 Dec; 60(12):1643-50. PubMed ID: 19000369
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression.
Dhar AK; Mahesh R; Jindal A; Devadoss T; Bhatt S
Chem Biol Drug Des; 2014 Dec; 84(6):721-31. PubMed ID: 24903617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
